| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 23 | 2020 | 533 | 5.590 |
Why?
|
| Breast Neoplasms | 49 | 2024 | 15694 | 1.980 |
Why?
|
| Hedgehog Proteins | 14 | 2020 | 424 | 1.790 |
Why?
|
| Xenograft Model Antitumor Assays | 26 | 2024 | 3821 | 1.600 |
Why?
|
| Epithelial Cells | 11 | 2020 | 1818 | 1.540 |
Why?
|
| Neoplastic Stem Cells | 11 | 2018 | 1443 | 1.500 |
Why?
|
| Breast | 10 | 2020 | 1344 | 1.500 |
Why?
|
| Morphogenesis | 5 | 2017 | 337 | 1.280 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2015 | 488 | 1.270 |
Why?
|
| Models, Biological | 13 | 2021 | 3254 | 1.140 |
Why?
|
| Signal Transduction | 31 | 2022 | 11965 | 1.130 |
Why?
|
| Patched-1 Receptor | 7 | 2019 | 48 | 1.050 |
Why?
|
| Triple Negative Breast Neoplasms | 13 | 2022 | 1215 | 1.040 |
Why?
|
| Epithelium | 7 | 2022 | 720 | 0.910 |
Why?
|
| Animals | 83 | 2024 | 59536 | 0.900 |
Why?
|
| Mammary Glands, Human | 6 | 2013 | 184 | 0.880 |
Why?
|
| Mice | 65 | 2022 | 34495 | 0.840 |
Why?
|
| Cell Proliferation | 22 | 2021 | 7226 | 0.840 |
Why?
|
| Lactation | 3 | 2020 | 210 | 0.750 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 1143 | 0.750 |
Why?
|
| Heterografts | 9 | 2024 | 733 | 0.730 |
Why?
|
| Milk Proteins | 1 | 2020 | 116 | 0.720 |
Why?
|
| Nanocapsules | 2 | 2017 | 28 | 0.700 |
Why?
|
| Nanotubes, Carbon | 2 | 2017 | 29 | 0.700 |
Why?
|
| Receptors, Cell Surface | 7 | 2018 | 862 | 0.690 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 1121 | 0.650 |
Why?
|
| Paracrine Communication | 3 | 2017 | 128 | 0.620 |
Why?
|
| Mammary Neoplasms, Animal | 5 | 2018 | 221 | 0.610 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2018 | 2359 | 0.610 |
Why?
|
| Drug Resistance, Neoplasm | 15 | 2021 | 5178 | 0.610 |
Why?
|
| Stem Cells | 4 | 2018 | 1213 | 0.590 |
Why?
|
| Cell Size | 2 | 2016 | 136 | 0.580 |
Why?
|
| Cell Line, Tumor | 28 | 2022 | 14551 | 0.570 |
Why?
|
| Smoothened Receptor | 6 | 2017 | 52 | 0.560 |
Why?
|
| Female | 78 | 2024 | 141928 | 0.550 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 8 | 0.550 |
Why?
|
| Mice, SCID | 14 | 2022 | 1869 | 0.550 |
Why?
|
| Transcription Factors | 6 | 2020 | 5270 | 0.520 |
Why?
|
| Mice, Transgenic | 11 | 2016 | 4143 | 0.510 |
Why?
|
| Claudins | 1 | 2014 | 47 | 0.500 |
Why?
|
| Neoplasms, Experimental | 2 | 2017 | 750 | 0.480 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 677 | 0.460 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3230 | 0.440 |
Why?
|
| Laminin | 2 | 2012 | 194 | 0.430 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 7222 | 0.430 |
Why?
|
| Collagen | 3 | 2012 | 752 | 0.420 |
Why?
|
| Cell Separation | 2 | 2019 | 612 | 0.420 |
Why?
|
| Cell Differentiation | 9 | 2020 | 4078 | 0.420 |
Why?
|
| Cisplatin | 2 | 2017 | 2432 | 0.420 |
Why?
|
| Proteoglycans | 2 | 2012 | 259 | 0.410 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 73 | 0.400 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 202 | 0.390 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 169 | 0.380 |
Why?
|
| Integrases | 3 | 2019 | 262 | 0.370 |
Why?
|
| Veratrum Alkaloids | 2 | 2017 | 32 | 0.360 |
Why?
|
| Humans | 80 | 2024 | 261506 | 0.350 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 14289 | 0.350 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 4821 | 0.340 |
Why?
|
| Mammary Tumor Virus, Mouse | 4 | 2018 | 122 | 0.340 |
Why?
|
| Genes, Homeobox | 2 | 2000 | 147 | 0.340 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 148 | 0.320 |
Why?
|
| Progesterone | 5 | 2017 | 513 | 0.310 |
Why?
|
| Myeloid-Derived Suppressor Cells | 2 | 2020 | 100 | 0.310 |
Why?
|
| Mice, Knockout | 10 | 2020 | 5710 | 0.300 |
Why?
|
| Trans-Activators | 3 | 2004 | 1555 | 0.300 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2007 | 45 | 0.290 |
Why?
|
| Ascomycota | 2 | 1997 | 31 | 0.290 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2020 | 973 | 0.280 |
Why?
|
| Patched Receptors | 5 | 2010 | 46 | 0.280 |
Why?
|
| Fungal Proteins | 2 | 1997 | 254 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2022 | 8873 | 0.270 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 388 | 0.260 |
Why?
|
| Taxoids | 5 | 2013 | 967 | 0.250 |
Why?
|
| Spheroids, Cellular | 3 | 2014 | 222 | 0.250 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2016 | 363 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 5 | 2017 | 2314 | 0.250 |
Why?
|
| Everolimus | 1 | 2016 | 415 | 0.250 |
Why?
|
| Mice, Nude | 10 | 2021 | 4307 | 0.240 |
Why?
|
| Mice, Inbred NOD | 6 | 2018 | 905 | 0.240 |
Why?
|
| Estrogen Receptor alpha | 3 | 2021 | 701 | 0.230 |
Why?
|
| Apoptosis | 12 | 2021 | 7591 | 0.230 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2021 | 840 | 0.220 |
Why?
|
| CD24 Antigen | 3 | 2013 | 85 | 0.220 |
Why?
|
| Research Design | 2 | 2009 | 1544 | 0.220 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2014 | 494 | 0.220 |
Why?
|
| Adipose Tissue | 2 | 2022 | 769 | 0.220 |
Why?
|
| Precancerous Conditions | 3 | 2018 | 1058 | 0.210 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2019 | 607 | 0.210 |
Why?
|
| Genes, Reporter | 3 | 2014 | 798 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2021 | 810 | 0.200 |
Why?
|
| Ribonuclease III | 2 | 2013 | 182 | 0.200 |
Why?
|
| Drosophila Proteins | 2 | 2016 | 858 | 0.200 |
Why?
|
| RNA Helicases | 1 | 2022 | 101 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2011 | 1498 | 0.200 |
Why?
|
| Heterozygote | 4 | 2011 | 1020 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 30 | 0.200 |
Why?
|
| Neuropilin-2 | 1 | 2020 | 21 | 0.190 |
Why?
|
| Stem Cell Niche | 2 | 2012 | 94 | 0.190 |
Why?
|
| Pregnancy | 9 | 2020 | 7573 | 0.190 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 669 | 0.190 |
Why?
|
| Mutation | 10 | 2021 | 15179 | 0.190 |
Why?
|
| Wnt Signaling Pathway | 2 | 2014 | 430 | 0.190 |
Why?
|
| Estrogens | 3 | 2017 | 751 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 255 | 0.190 |
Why?
|
| Spliceosomes | 1 | 2021 | 75 | 0.190 |
Why?
|
| Neoplasm Transplantation | 7 | 2019 | 1519 | 0.190 |
Why?
|
| Membrane Proteins | 3 | 2009 | 2819 | 0.180 |
Why?
|
| Neoplasm Metastasis | 7 | 2021 | 5112 | 0.180 |
Why?
|
| Sexual Maturation | 2 | 2019 | 65 | 0.180 |
Why?
|
| Transplants | 1 | 2020 | 52 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2020 | 96 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 160 | 0.180 |
Why?
|
| Insect Proteins | 1 | 1999 | 91 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 1678 | 0.170 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 57 | 0.170 |
Why?
|
| Organoids | 1 | 2022 | 287 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 755 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 266 | 0.170 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 123 | 0.170 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2018 | 13 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 376 | 0.170 |
Why?
|
| Pituitary Gland | 1 | 2019 | 150 | 0.170 |
Why?
|
| Transcriptome | 4 | 2021 | 1859 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2020 | 1664 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 1546 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 185 | 0.160 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 38 | 0.160 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 550 | 0.160 |
Why?
|
| Precision Medicine | 3 | 2022 | 1154 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 32 | 0.160 |
Why?
|
| Cell Plasticity | 1 | 2018 | 66 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 1999 | 354 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 1547 | 0.150 |
Why?
|
| Response Elements | 1 | 2018 | 193 | 0.150 |
Why?
|
| Neoplasms | 7 | 2021 | 15193 | 0.150 |
Why?
|
| Glycolysis | 1 | 2020 | 519 | 0.150 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 1997 | 6 | 0.150 |
Why?
|
| Endoribonucleases | 1 | 2018 | 107 | 0.150 |
Why?
|
| Lentivirus | 2 | 2014 | 169 | 0.150 |
Why?
|
| Receptors, Estrogen | 5 | 2012 | 2086 | 0.150 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 111 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2010 | 347 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 521 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 3639 | 0.150 |
Why?
|
| Cell Shape | 1 | 2017 | 128 | 0.150 |
Why?
|
| Peptides | 3 | 2018 | 1479 | 0.140 |
Why?
|
| Base Sequence | 5 | 2011 | 4917 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 6942 | 0.140 |
Why?
|
| Tamoxifen | 2 | 2011 | 876 | 0.140 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 783 | 0.140 |
Why?
|
| Carboplatin | 1 | 2019 | 823 | 0.140 |
Why?
|
| Mesoderm | 2 | 2009 | 404 | 0.140 |
Why?
|
| ras Proteins | 1 | 2020 | 770 | 0.140 |
Why?
|
| Hypogonadism | 1 | 2019 | 257 | 0.140 |
Why?
|
| Homozygote | 3 | 2011 | 717 | 0.140 |
Why?
|
| Phenotype | 4 | 2013 | 6295 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2013 | 3033 | 0.130 |
Why?
|
| Body Patterning | 1 | 2016 | 212 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 694 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 470 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2017 | 269 | 0.130 |
Why?
|
| Gene Expression Profiling | 8 | 2015 | 5159 | 0.130 |
Why?
|
| Biological Evolution | 1 | 1996 | 278 | 0.130 |
Why?
|
| Hyaluronan Receptors | 3 | 2013 | 249 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2016 | 154 | 0.130 |
Why?
|
| Time Factors | 6 | 2013 | 12926 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 345 | 0.130 |
Why?
|
| Wnt1 Protein | 2 | 2018 | 103 | 0.130 |
Why?
|
| Proteomics | 2 | 2020 | 1380 | 0.130 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 406 | 0.120 |
Why?
|
| Dioxolanes | 1 | 2014 | 41 | 0.120 |
Why?
|
| Eye | 1 | 2016 | 301 | 0.120 |
Why?
|
| Fluorescence | 1 | 2014 | 195 | 0.120 |
Why?
|
| Separase | 1 | 2014 | 32 | 0.120 |
Why?
|
| Drug Repositioning | 1 | 2014 | 54 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1516 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2018 | 1038 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2020 | 1493 | 0.120 |
Why?
|
| DNA Repair | 2 | 2013 | 1872 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 5395 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2021 | 1230 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 986 | 0.110 |
Why?
|
| Benzene Derivatives | 1 | 2013 | 23 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 336 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 217 | 0.110 |
Why?
|
| src-Family Kinases | 1 | 2016 | 478 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 7789 | 0.110 |
Why?
|
| Propionates | 1 | 2013 | 71 | 0.110 |
Why?
|
| Kinetics | 1 | 2016 | 2049 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2016 | 448 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 519 | 0.110 |
Why?
|
| Cell Movement | 3 | 2020 | 2466 | 0.110 |
Why?
|
| Drug Combinations | 2 | 2012 | 621 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2016 | 2084 | 0.110 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 11538 | 0.110 |
Why?
|
| Integrin beta1 | 1 | 2013 | 126 | 0.110 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 4233 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Sulfones | 1 | 2013 | 143 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 1033 | 0.100 |
Why?
|
| Estradiol | 2 | 2012 | 748 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 342 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2011 | 1037 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 1581 | 0.100 |
Why?
|
| Zinc Finger Protein Gli2 | 2 | 2001 | 30 | 0.100 |
Why?
|
| Carcinogenesis | 2 | 2016 | 1026 | 0.100 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 10331 | 0.100 |
Why?
|
| Receptors, Notch | 2 | 2013 | 383 | 0.100 |
Why?
|
| Molecular Sequence Data | 6 | 2010 | 6089 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 1146 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 769 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 679 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 126 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 854 | 0.100 |
Why?
|
| Uterus | 2 | 2019 | 678 | 0.100 |
Why?
|
| Estrogen Antagonists | 1 | 2011 | 184 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2018 | 5637 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2011 | 2074 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 334 | 0.090 |
Why?
|
| Neutral Red | 1 | 2009 | 2 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 5 | 2013 | 2518 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 839 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 117 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 668 | 0.090 |
Why?
|
| Cytokines | 1 | 1999 | 2809 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2016 | 992 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 299 | 0.090 |
Why?
|
| Cadherins | 2 | 2010 | 660 | 0.090 |
Why?
|
| Computational Biology | 1 | 2016 | 1271 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 259 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2011 | 557 | 0.090 |
Why?
|
| Cell Hypoxia | 3 | 2017 | 328 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2001 | 270 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2012 | 1987 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2019 | 2669 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 5047 | 0.080 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1989 | 53 | 0.080 |
Why?
|
| Stromal Cells | 2 | 2011 | 825 | 0.080 |
Why?
|
| Mitochondria | 1 | 2016 | 1282 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 280 | 0.080 |
Why?
|
| Lectins | 1 | 1989 | 151 | 0.080 |
Why?
|
| Graft Survival | 1 | 2012 | 1062 | 0.080 |
Why?
|
| Anthracyclines | 1 | 2010 | 331 | 0.080 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 1360 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 6009 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2008 | 300 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2009 | 429 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2010 | 217 | 0.080 |
Why?
|
| Phosphorylation | 4 | 2018 | 4804 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2013 | 6150 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 10035 | 0.080 |
Why?
|
| Monocytes | 1 | 2012 | 788 | 0.080 |
Why?
|
| Cell Communication | 1 | 2011 | 509 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 943 | 0.080 |
Why?
|
| Embryo Implantation | 1 | 2010 | 278 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 598 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 459 | 0.070 |
Why?
|
| Receptors, Progesterone | 5 | 2010 | 1392 | 0.070 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2006 | 41 | 0.070 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 101 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 110 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2021 | 1064 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 483 | 0.070 |
Why?
|
| Proteins | 2 | 1999 | 1963 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2013 | 2508 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2014 | 1694 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 1999 | 844 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 1062 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 471 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1008 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 1997 | 469 | 0.070 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 1082 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 658 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2007 | 666 | 0.060 |
Why?
|
| Transgenes | 1 | 2007 | 557 | 0.060 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 260 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 3869 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2010 | 2295 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 1997 | 330 | 0.060 |
Why?
|
| Macrophages | 1 | 2011 | 1304 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 1265 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2017 | 3341 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 878 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 1656 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 1450 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 3101 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 1130 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 984 | 0.060 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 3343 | 0.060 |
Why?
|
| Mammography | 1 | 2009 | 1010 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2011 | 1423 | 0.050 |
Why?
|
| Tumor Microenvironment | 3 | 2018 | 2864 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6207 | 0.050 |
Why?
|
| Protein Array Analysis | 2 | 2018 | 501 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 803 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 997 | 0.050 |
Why?
|
| Prognosis | 5 | 2021 | 21713 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2010 | 1471 | 0.050 |
Why?
|
| Sarcoma | 1 | 2012 | 1725 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3552 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 15862 | 0.050 |
Why?
|
| Transplantation | 1 | 2001 | 56 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 79 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2001 | 205 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 3 | 2010 | 4975 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 852 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 10001 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 2 | 2014 | 1290 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 1999 | 110 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2007 | 1549 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 149 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 30 | 0.040 |
Why?
|
| Genomics | 2 | 2021 | 2738 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 7548 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 432 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2011 | 886 | 0.040 |
Why?
|
| Alagille Syndrome | 1 | 1999 | 44 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 205 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2330 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 68 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 152 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 324 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 639 | 0.040 |
Why?
|
| Survival Rate | 3 | 2021 | 12221 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 370 | 0.040 |
Why?
|
| Cell Survival | 2 | 2018 | 3045 | 0.040 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2018 | 83 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2020 | 209 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 1217 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2019 | 188 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 652 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 62 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 4053 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 338 | 0.040 |
Why?
|
| Keratins | 1 | 2019 | 330 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 731 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 124 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 1946 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 672 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2017 | 133 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 115 | 0.040 |
Why?
|
| Carcinogens | 2 | 2009 | 384 | 0.040 |
Why?
|
| Neurospora crassa | 1 | 1997 | 6 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 745 | 0.040 |
Why?
|
| Genes | 1 | 2018 | 491 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 57 | 0.040 |
Why?
|
| Haplotypes | 1 | 1999 | 856 | 0.040 |
Why?
|
| Neurospora | 1 | 1996 | 2 | 0.040 |
Why?
|
| Hypocreales | 1 | 1996 | 2 | 0.040 |
Why?
|
| Reproduction | 1 | 2019 | 253 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1997 | 73 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1997 | 84 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 1213 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 630 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1996 | 264 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2017 | 114 | 0.040 |
Why?
|
| Polyubiquitin | 1 | 2016 | 23 | 0.040 |
Why?
|
| Pericytes | 1 | 2017 | 96 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2018 | 621 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 5767 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 2016 | 75 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 493 | 0.030 |
Why?
|
| Male | 7 | 2021 | 123000 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 250 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 889 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2011 | 1529 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 3536 | 0.030 |
Why?
|
| Alleles | 1 | 2001 | 2437 | 0.030 |
Why?
|
| Ovary | 1 | 2019 | 668 | 0.030 |
Why?
|
| Patients | 1 | 2017 | 245 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2000 | 778 | 0.030 |
Why?
|
| Testis | 1 | 2019 | 717 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 1643 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 487 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 446 | 0.030 |
Why?
|
| Proteome | 1 | 2018 | 561 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 619 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 4849 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2054 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 370 | 0.030 |
Why?
|
| Rhodamines | 1 | 2014 | 49 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 717 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 105 | 0.030 |
Why?
|
| Triazoles | 1 | 2018 | 617 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 59 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 2450 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 661 | 0.030 |
Why?
|
| United States | 2 | 2022 | 15433 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 227 | 0.030 |
Why?
|
| Exome | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 289 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 575 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 463 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 2013 | 12 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2013 | 29 | 0.030 |
Why?
|
| Genotype | 1 | 2001 | 4109 | 0.030 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 323 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 503 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 942 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2013 | 110 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2020 | 1996 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 749 | 0.030 |
Why?
|
| Clonal Evolution | 1 | 2015 | 253 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 475 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1144 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 99 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 1162 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 216 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 834 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 289 | 0.030 |
Why?
|
| Research | 1 | 2015 | 415 | 0.030 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2011 | 6 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2011 | 14 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 667 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2013 | 295 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 139 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 992 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 445 | 0.030 |
Why?
|
| Solvents | 1 | 2011 | 66 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 663 | 0.030 |
Why?
|
| Platinum | 1 | 2011 | 138 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 2483 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 448 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2013 | 382 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1165 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2017 | 1048 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 354 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2010 | 97 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 838 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2010 | 52 | 0.020 |
Why?
|
| Epirubicin | 1 | 2010 | 157 | 0.020 |
Why?
|
| Pyridines | 1 | 2017 | 1244 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 208 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 286 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 260 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2216 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 829 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2011 | 342 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2009 | 32 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 377 | 0.020 |
Why?
|
| Ranidae | 1 | 1989 | 4 | 0.020 |
Why?
|
| Turtles | 1 | 1989 | 11 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 392 | 0.020 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 1989 | 7 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 108 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 671 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 1399 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2013 | 747 | 0.020 |
Why?
|
| Decidua | 1 | 2010 | 154 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 4549 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 634 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 700 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2008 | 3890 | 0.020 |
Why?
|
| Parity | 1 | 2008 | 139 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 1152 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 92 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1053 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2009 | 200 | 0.020 |
Why?
|
| Calcinosis | 1 | 2011 | 423 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2013 | 1385 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1129 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 644 | 0.020 |
Why?
|
| Cattle | 1 | 1989 | 783 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2007 | 69 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 344 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 1183 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 2006 | 18 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2007 | 120 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1989 | 931 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 362 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2007 | 170 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1989 | 482 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 2489 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 995 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 1682 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 703 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2010 | 1944 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 850 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 1954 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1989 | 1258 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 3570 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2045 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3518 | 0.020 |
Why?
|
| Pyridones | 1 | 2007 | 348 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 576 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 2944 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 32848 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2007 | 428 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 3438 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3981 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.010 |
Why?
|
| Quinazolines | 1 | 2008 | 923 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 3001 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 14889 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1991 | 2488 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 3441 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 3443 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 1555 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6086 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 3719 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 5377 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 29902 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 13658 | 0.010 |
Why?
|
| Adult | 3 | 2009 | 77950 | 0.010 |
Why?
|
| Middle Aged | 3 | 2009 | 86204 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 6869 | 0.010 |
Why?
|
| Aged | 2 | 2009 | 70117 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 17523 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1991 | 329 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1991 | 202 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1991 | 1094 | 0.000 |
Why?
|